Targeting interleukin-17 in patients with active rheumatoid arthritis: rationale and clinical potential
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting interleukin-17 in patients with active rheumatoid arthritis: rationale and clinical potential
Authors
Keywords
-
Journal
Therapeutic Advances in Musculoskeletal Disease
Volume 5, Issue 3, Pages 141-152
Publisher
SAGE Publications
Online
2013-05-24
DOI
10.1177/1759720x13485328
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of Functional Roles for Both IL-17RB and IL-17RA in Mediating IL-25-Induced Activities
- (2014) E. A. Rickel et al. JOURNAL OF IMMUNOLOGY
- Identification of shared citrullinated immunological targets in the lungs and joints of patients with rheumatoid arthritis
- (2012) A Jimmy Ytterberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Incomplete response of inflammatory arthritis to TNFα blockade is associated with the Th17 pathway
- (2012) Saba Alzabin et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study
- (2012) Mark C Genovese et al. ANNALS OF THE RHEUMATIC DISEASES
- Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatment
- (2012) Vibeke Strand et al. ANNALS OF THE RHEUMATIC DISEASES
- Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomised, double-blind, placebo-controlled, phase II regimen-finding study
- (2012) P. Rich et al. BRITISH JOURNAL OF DERMATOLOGY
- Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study
- (2012) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- TWEAK promotes the production of Interleukin-17 in rheumatoid arthritis
- (2012) Jin-Sil Park et al. CYTOKINE
- Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
- (2012) Kim A. Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
- (2012) Craig Leonardi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic Review and Meta-Analysis of the Efficacy and Safety of Existing TNF Blocking Agents in Treatment of Rheumatoid Arthritis
- (2012) Kalle J. Aaltonen et al. PLoS One
- Frequency of Th17 CD4+ T Cells in Early Rheumatoid Arthritis: A Marker of Anti-CCP Seropositivity
- (2012) Irene Arroyo-Villa et al. PLoS One
- Interleukin-17A upregulates receptor activator of NF-κB on osteoclast precursors
- (2012) Iannis E Adamopoulos et al. ARTHRITIS RESEARCH & THERAPY
- Co-morbidities in established rheumatoid arthritis
- (2011) Nicola J. Gullick et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- The economic burden of rheumatoid arthritis: beyond health care costs
- (2011) Wei Zhang et al. CLINICAL RHEUMATOLOGY
- Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA
- (2011) Siham Ali Metawi et al. CLINICAL RHEUMATOLOGY
- Functional Specialization of Interleukin-17 Family Members
- (2011) Yoichiro Iwakura et al. IMMUNITY
- Th17 Cells, Not IL-17+ T Cells, Drive Arthritic Bone Destruction in Mice and Humans
- (2011) B. Pollinger et al. JOURNAL OF IMMUNOLOGY
- Foxp3+ Regulatory T Cells of Psoriasis Patients Easily Differentiate into IL-17A-Producing Cells and Are Found in Lesional Skin
- (2011) H. Jorn Bovenschen et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Anti-CCP antibodies: the past, the present and the future
- (2011) Walther J. van Venrooij et al. Nature Reviews Rheumatology
- The Pathogenesis of Rheumatoid Arthritis
- (2011) Iain B. McInnes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity
- (2011) A. Puel et al. SCIENCE
- TWEAK and Fn14 expression in the pathogenesis of joint inflammation and bone erosion in rheumatoid arthritis
- (2011) Anak ASSK Dharmapatni et al. ARTHRITIS RESEARCH & THERAPY
- Mast cells are the main interleukin 17-positive cells in anticitrullinated protein antibody-positive and -negative rheumatoid arthritis and osteoarthritis synovium
- (2011) Jolien Suurmond et al. ARTHRITIS RESEARCH & THERAPY
- Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapy
- (2011) Der-Yuan Chen et al. ARTHRITIS RESEARCH & THERAPY
- Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis
- (2010) C. Salliot et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-17A- versus IL-17F-induced intracellular signal transduction pathways and modulation by IL-17RA and IL-17RC RNA interference in rheumatoid synoviocytes
- (2010) A. Hot et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
- (2010) J. S. Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study
- (2010) M. C. Genovese et al. ARTHRITIS AND RHEUMATISM
- Therapeutic potential of anti-interleukin-17A aptamer: Suppression of interleukin-17A signaling and attenuation of autoimmunity in two mouse models
- (2010) Akira Ishiguro et al. ARTHRITIS AND RHEUMATISM
- Anti-IL-17A therapy protects against bone erosion in experimental models of rheumatoid arthritis
- (2010) Cheng-Chi Chao et al. AUTOIMMUNITY
- Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease
- (2010) Reiko M. Onishi et al. IMMUNOLOGY
- The IL-17 Family Cytokines in Immunity and Disease
- (2010) Rajita Pappu et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I
- (2010) Anne Puel et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines
- (2010) Kai Kisand et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cutting Edge: Mast Cells Express IL-17A in Rheumatoid Arthritis Synovium
- (2010) A. J. Hueber et al. JOURNAL OF IMMUNOLOGY
- Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis
- (2010) W. Hueber et al. Science Translational Medicine
- IL-17 and Th17 Cells
- (2009) Thomas Korn et al. Annual Review of Immunology
- Causes of death in patients with rheumatoid arthritis from 1971 to 1991 with special reference to autopsy
- (2009) Riitta Koivuniemi et al. CLINICAL RHEUMATOLOGY
- Interleukin-17 and Type 17 Helper T Cells
- (2009) Pierre Miossec et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-α, Oncostatin M and response to biologic therapies
- (2009) Ellen M Moran et al. ARTHRITIS RESEARCH & THERAPY
- Heterogeneity of human effector CD4+ T cells
- (2009) Francesco Annunziato et al. ARTHRITIS RESEARCH & THERAPY
- Combined blockade of granulocyte-macrophage colony stimulating factor and interleukin 17 pathways potently suppresses chronic destructive arthritis in a tumour necrosis factor -independent mouse model
- (2008) C Plater-Zyberk et al. ANNALS OF THE RHEUMATIC DISEASES
- Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells
- (2008) H. J. P. M. Koenen et al. BLOOD
- Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety
- (2008) Alberto Alonso-Ruiz et al. BMC MUSCULOSKELETAL DISORDERS
- Foxp3 Inhibits RORγt-mediatedIL-17AmRNA Transcription through Direct Interaction with RORγt
- (2008) Kenji Ichiyama et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now